Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/24/19 → 12/13/24 |
Funding
- Covance: $113,091.00
A Phase 3, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A Inhalation Solution Delivered via the PARI Investigational eFLOW Device plus Standard of Care in the Treatme
- Nandavaram, Sravanthi (PI)
- Rockich, Anna (CoI)
- Baz, Maher (Former PI)
- Sekela, Michael (Former PI)